Building and Evaluating a Robust IP Portfolio

Life Sciences Seminar Series

01/14/2014 08:30 a.m. - 10:00 a.m.

Emerging Companies + Venture Capital and Life Sciences

Morrison & Foerster
425 Market Street
San Francisco, CA 94105

Shannon Reaney and Janet Xiao

Shannon Reaney and Janet Xiao

Seminar

Jennifer Dubman
jdubman@mofo.com
(415) 268-6742

In this session, we examine the current legal environment for developing a strategically strong patent portfolio. We also explore what investors need to look for in evaluating the intellectual assets of a company. This seminar draws specific references to antibody and small molecule technologies—with broader implications across life sciences and healthcare—as well as addresses some of the regulatory issues specific to both generic and branded pharmaceuticals.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2017 Morrison & Foerster LLP. All rights reserved.